{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:01:33Z","timestamp":1790758893068,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"French Ministry of Health"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003383","name":"CRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003383","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Transregio","award":["205\/2"],"award-info":[{"award-number":["205\/2"]}]},{"name":"Transregio","award":["314061271"],"award-info":[{"award-number":["314061271"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The CHIRACIC trail supported the beneficial effect of adrenalectomy on hypertension in patients with unilateral adrenal incidentalomas associated with mild autonomous cortisol secretion (MACS). Additional assessments evaluated the impact of adrenalectomy on body weight excess, metabolic abnormalities and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicenter superiority open-label randomized trial comparing adrenalectomy to conservative management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following a run-in phase to control hypertension, receive lifestyle advice and treatment for comorbidities, patients underwent a workup including measurement of body mass index, visceral and total fat, fat mass, fasting blood glucose, HbA1c, oral glucose tolerance test, plasma lipids, and quality of life (QoL). Following randomization, assessment of comorbidities and adaptation of their treatment were performed every 3 months for 13 months. Workup was repeated at the end of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-eight patients were randomly assigned to adrenalectomy (n = 23) and conservative management (n = 25). 93%, 71% and 90% of patients were overweight\/obese, prediabetics\/diabetics and dyslipidemic, respectively. There was no statistically significant improvement in anthropometric and metabolic parameters after adrenalectomy as compared to conservative management: 21% and 4% of adrenalectomized and conservatively treated obese\/overweight patients lost &amp;gt; 5% of body weight, respectively (difference 22%, 95% CI: \u22122% to 39%). Glycemic status improved in 44% and 33% of adrenalectomized and conservatively treated dysglycemic patients, respectively (difference 10%, 95% CI: \u221222% to 43%). Dyslipidemia improved in 20% of adrenalectomized and none of conservatively treated dyslipidemic patients. Changes in QoL were not different between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The beneficial effects of adrenalectomy on excess weight, metabolic disorders and QoL demonstrated in the CHIRACIC trial are more limited than those observed for hypertension. Additional randomized interventional studies involving a larger number of patients are needed to support the use of adrenalectomy in the treatment of these comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag142","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:41:16Z","timestamp":1786448476000},"page":"421-430","source":"Crossref","is-referenced-by-count":0,"title":["Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-3306","authenticated-orcid":false,"given":"A","family":"Tabarin","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolism and Nutrition, Hopital Haut Leveque, CHU Bordeaux , 336604 Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Espiard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Oncology and Metabolism, CHU Lille, Inserm U1190, EGID, University of Lille , 59045 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Deutschbein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of W\u00fcrzburg , 97080 W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-4276","authenticated-orcid":false,"given":"L","family":"Amar","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou, Hypertension Unit, Universit\u00e9 Paris-Cit\u00e9, AP-HP , 75015 Paris ,","place":["France"]},{"name":"Adrenal Referral Center, Universit\u00e9 Paris Cit\u00e9, AP-HP , 75015 \u00a0","place":["France"]},{"name":"Inserm Paris Cardiovascular Research Center , 75015 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Vezzossi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolism, CHU Rangueil-Larrey , 31059 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-8906","authenticated-orcid":false,"given":"G","family":"Di Dalmazi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes Prevention and Care, IRCCS AOU di Bologna , 40138 Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences\u2014DIMEC\u2014Alma Mater Studiorum, University of Bologna , 40138 Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Reznik","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Caen Normandy University Hospital , Caen cedex 9 14033 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-5631","authenticated-orcid":false,"given":"J","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bic\u00eatre Hospital , Le Kremlin-Bic\u00eatre F-94275 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Desailloud","sequence":"additional","affiliation":[{"name":"Department of Endocrinology-Diabetology-Nutrition, CHU Amiens Picardie\u2014Universit\u00e9 Picardie Jules Verne , Amiens 80000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Goichot","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hopital de Hautepierre\u2013Hopitaux Universitaires de Strasbourg , 67200 Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4579-4129","authenticated-orcid":false,"given":"D","family":"Drui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Nutrition, L\u2019institut du Thorax, CHU Nantes, Nantes Universit\u00e9 , 44093 Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-0906","authenticated-orcid":false,"given":"G","family":"Assi\u00e9","sequence":"additional","affiliation":[{"name":"CNRS, INSERM, Institut Cochin, Universit\u00e9 Paris Cit\u00e9 , Paris F-75014 ,","place":["France"]},{"name":"Department of Endocrinology, Center for Rare Adrenal Diseases, AP-HP, H\u00f4pital Cochin , Paris F-75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-9648","authenticated-orcid":false,"given":"H","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Inserm, NorDiC UMR 1239, CHU Rouen, Department of Endocrinology, Diabetes and Metabolic Diseases, Univ Rouen Normandie , Rouen F-76000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-3155","authenticated-orcid":false,"given":"K","family":"Mai","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, 10117 Humboldt-Universit\u00e4t zu, Berlin"},{"name":"Department of Endocrinology and Metabolism"},{"name":"European Reference Network on Rare Endocrine Diseases (ENDO-ERN), Pituitary Tumor Center of Excellence at Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate Member of Freie Universit\u00e4t Berlin, 10117 Humboldt-Universit\u00e4t zu, Berlin"},{"name":"Berlin Institute of Health , Berlin 10117 ,","place":["Germany"]},{"name":"Department of Human Nutrition, German Institute of Human Nutrition Potsdam-Rehbru\u0308cke , 14558 Nuthetal ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD) , 85764 M\u00fcnchen-Neuherberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"F","family":"Castinetti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Assistance Publique-Hopitaux de Marseille, French Reference Center for Rare Pituitary Diseases, EURACAN European Expert Center on Rare Pituitary Tumors, La Conception Hospital, Aix Marseille University , Marseille F-13385 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Laboureau","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Diabetology Nutrition, Hopitaux Universitaires D\u2019Angers , 49933 Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Terzolo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin , Orbassano 10043 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferriere","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolism and Nutrition, Hopital Haut Leveque, CHU Bordeaux , 336604 Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Georget","sequence":"additional","affiliation":[{"name":"Medical Information Department, CHU Bordeaux , 33000 Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-1886","authenticated-orcid":false,"given":"E","family":"Frison","sequence":"additional","affiliation":[{"name":"Medical Information Department, CHU Bordeaux , 33000 Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"M C","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Oncology and Metabolism, CHU Lille, Inserm U1190, EGID, University of Lille , 59045 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-7749","authenticated-orcid":false,"given":"P","family":"Gosse","sequence":"additional","affiliation":[{"name":"Department of Arterial Hypertension, CHU Bordeaux , 33000 Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"M","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of W\u00fcrzburg , 97080 W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"1","key":"2026093004230106600_lvag142-B1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026093004230106600_lvag142-B2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2026093004230106600_lvag142-B3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"issue":"4","key":"2026093004230106600_lvag142-B4","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026093004230106600_lvag142-B5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2026093004230106600_lvag142-B6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"issue":"12","key":"2026093004230106600_lvag142-B7","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004230106600_lvag142-B8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2026093004230106600_lvag142-B9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S2213-8587(25)00062-2","article-title":"Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial","volume":"13","author":"Tabarin","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2026093004230106600_lvag142-B10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/SLA.0000000000006183","article-title":"Adrenalectomy improves body weight, glucose, and blood pressure control in patients with mild autonomous cortisol secretion: results of an randomized controlled trial by the co-work of adrenal research (COAR) study","volume":"279","author":"Koh","year":"2024","journal-title":"Ann Surg"},{"issue":"7","key":"2026093004230106600_lvag142-B11","doi-asserted-by":"publisher","DOI":"10.1530\/EC-25-0361","article-title":"Randomized trial studying metabolic outcomes and quality of life after adrenalectomy versus conservative management for mild autonomous cortisol secretion","volume":"14","author":"Ueland","year":"2025","journal-title":"Endocr Connect"},{"issue":"6","key":"2026093004230106600_lvag142-B12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"issue":"5","key":"2026093004230106600_lvag142-B13","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1093\/ejendo\/lvag072","article-title":"Impact of diagnosis and targeted interventions on the quality of life and neuropsychiatric outcomes of patients with adrenal tumours: a systematic review","volume":"194","author":"Ruggiero","year":"2026","journal-title":"Eur J Endocrinol"},{"key":"2026093004230106600_lvag142-B14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026093004230106600_lvag142-B15","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Supplement_1","key":"2026093004230106600_lvag142-B16","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"10285","key":"2026093004230106600_lvag142-B17","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Blood Pressure Lowering Treatment Trialists Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"2026093004230106600_lvag142-B18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2026093004230106600_lvag142-B19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"25","key":"2026093004230106600_lvag142-B20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2026093004230106600_lvag142-B21","first-page":"233","article-title":"The defined daily dose system (DDD) for drug utilization review","volume":"21","author":"Wertheimer","year":"1986","journal-title":"Hosp Pharm"},{"issue":"29","key":"2026093004230106600_lvag142-B22","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1002\/sim.5990","article-title":"Traditional multiplicity adjustment methods in clinical trials","volume":"32","author":"Dmitrienko","year":"2013","journal-title":"Stat Med"},{"key":"2026093004230106600_lvag142-B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1374711","article-title":"Comparison of adrenalectomy with conservative treatment on mild autonomous cortisol secretion: a systematic review and meta-analysis","volume":"15","author":"Khadembashiri","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026093004230106600_lvag142-B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2026093004230106600_lvag142-B25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"2026093004230106600_lvag142-B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cen.13512","article-title":"Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026093004230106600_lvag142-B27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000549751","article-title":"European Association for the Study of Obesity Position Statement on the diagnosis and management of obesity in older adults","volume":"19","author":"Di Vincenzo","year":"2026","journal-title":"Obes Facts"},{"issue":"6","key":"2026093004230106600_lvag142-B28","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1210\/clinem\/dgaf693","article-title":"Cardiometabolic outcomes after surgical remission of endogenous hypercortisolism: a prospective cohort study","volume":"111","author":"Chacko","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004230106600_lvag142-B29","doi-asserted-by":"publisher","first-page":"106126","DOI":"10.1016\/j.ebiom.2026.106126","article-title":"Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion","volume":"124","author":"Prete","year":"2026","journal-title":"EBioMedicine"},{"issue":"2","key":"2026093004230106600_lvag142-B30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/EJE-17-0109","article-title":"Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome","volume":"177","author":"Di Dalmazi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026093004230106600_lvag142-B31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ejendo\/lvad073","article-title":"Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study","volume":"188","author":"Zhang","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004230106600_lvag142-B32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11102-022-01218-y","article-title":"Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome","volume":"25","author":"He","year":"2022","journal-title":"Pituitary"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag142\/70611077\/lvag142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/421\/70611077\/lvag142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/421\/70611077\/lvag142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:23:10Z","timestamp":1790756590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/3\/421\/8758943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag142","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,11]]}}}